Patent · US Active

Recurrent gene fusions in prostate cancer

US10041123B2 · kind B2 · utility

0Cited by
54References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2007
Grant dateAug 7, 2018
Priority date
Expiry dateMar 31, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/81
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Recurrent gene fusions in prostate cancer of androgen regulated genes or housekeeping genes and ETS family member genes are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.